TLDR
- SRx Health Solutions acquires 4.99% equity stake in Smartkem via shelf take down
- SRXH also secures convertible preferred securities through a private placement deal
- SRx and EMJX Crypto Technologies move forward with a definitive merger agreement
- SRXH stock climbs 3.15% to $0.1246 amid strategic acquisition and merger news
- SEC Form S-4 Registration filed as SRx prepares for its crypto treasury transformation
SRx Health Solutions (SRXH) is making bold moves as it reshapes its corporate identity. The company’s stock rose 3.15% to $0.1246 on Monday, reflecting growing market attention. SRx Health Solutions announced the acquisition of a 4.99% equity stake in Smartkem, Inc. through a shelf take down.
SRx Health Solutions Inc., SRXH
SRx Health Solutions Targets Advanced Materials With Smartkem Investment
SRx Health Solutions executed the Smartkem stake purchase alongside a non-brokered private placement. Through that placement, the company also secured convertible preferred securities in Smartkem. Smartkem is a recognised leader in advanced materials, and the dual investment signals a calculated strategic expansion.
The move comes as SRx Health Solutions advances its pending merger with EMJ Crypto Technologies, known as EMJX. EMJX operates as a digital-asset treasury platform, and the merger agreement is already in place. Together, SRXH and EMJX are building a diversified portfolio that spans materials technology and digital assets.
SRx Health Solutions is positioning itself at the intersection of advanced technology and emerging financial infrastructure. The Smartkem acquisition adds a tangible asset layer to its evolving corporate structure. This dual-front approach strengthens the company’s appeal ahead of the formal merger closing.
EMJX Merger Drives SEC Filing and Shareholder Disclosure Process
SRx Health Solutions has filed a Registration Statement on Form S-4 with the U.S. Securities and Exchange Commission. The filing registers common stock to be issued in connection with the proposed EMJX transaction. It includes an Information Statement and Prospectus for company stockholders to review.
The SEC registration process is a critical step toward completing the SRx Health Solutions and EMJX combination. Stockholders are urged to read all relevant filings carefully before making any decisions. Additional documents may be filed as the transaction progresses toward its conclusion.
SRx Health Solutions and EMJX may submit further materials to the SEC as needed. All filings will be available at no cost through the SEC’s official website at www.sec.gov. The companies have made clear that website content does not form part of any SEC submission.


